Anesthesia | Eklavya Medical
vaccines
medical_services Main Specialty Domain lock Subscription Required

Anesthesia

Clinical anesthesiology, local and general anesthesia delivery systems, monitoring, and perioperative care.

verified Verified Medical Faculty menu_book 337 Q&A Modules
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 131 person Asked by .
bookmark_add

Pulmonary Hypertension — Classification, Pathophysiology & Perioperative Management Define pulmonary hypertension and describe its WHO classification [2]. Explain the pathophysiology of right ventricular failure in pulmonary hypertension [4]. Outline the specific anaesthetic goals and management for a patient with severe pulmonary hypertension presenting for non-cardiac surgery [4]."

collections Question Diagrams & Reference Images (1)
Question Reference Diagram
zoom_in View Image
description Clinical Response
" Q76 - Pulmonary Hypertension — Classification, Pathophysiology & Perioperative Management
Q76 · Paper II · 10 MARKS · Long Answer

Pulmonary Hypertension — Classification, Pathophysiology & Perioperative Management

Question: Define pulmonary hypertension and describe its WHO classification [2]. Explain the pathophysiology of right ventricular failure in pulmonary hypertension [4]. Outline the specific anaesthetic goals and management for a patient with severe pulmonary hypertension presenting for non-cardiac surgery [4].
Core ConceptPulmonary hypertension (PH) — mPAP ≥20 mmHg at rest — carries perioperative mortality of 7–24% for major non-cardiac surgery. The right ventricle is catastrophically vulnerable to acute afterload increases. Understanding RV physiology and the triggers of RV failure is key to safe anaesthetic management.

A. Definition & WHO Classification2 marks

Definition (ESC/ERS 2022): mPAP ≥20 mmHg at right heart catheterisation; PAH (Group 1) additionally requires PVR >2 Wood units AND PAWP ≤15 mmHg (pre-capillary).

WHO GroupMechanismExamples
Group 1 – PAHSmooth muscle hypertrophy + intimal proliferation + in-situ thrombosis → ↑PVR (pre-capillary)Idiopathic PAH; scleroderma (highest risk); Eisenmenger; drug-induced
Group 2 – Left heart disease↑LA pressure → pulmonary venous hypertension (post-capillary)LV failure; mitral stenosis; constrictive pericarditis
Group 3 – Lung disease/hypoxiaHypoxic pulmonary vasoconstriction → chronic ↑PVRCOPD; ILD; OSA; high-altitude PH
Group 4 – CTEPHUnresolved PE → organised thrombus → mechanical obstructionComplicates 2–4% of acute PE; surgically curable
Group 5 – MultifactorialHeterogeneousHaemolytic anaemia, sarcoidosis, fibrosing mediastinitis

B. Pathophysiology of RV Failure4 marks

  • Normal RV: thin-walled, low pressure (~25 mmHg), high compliance chamber; tolerates volume but not sudden afterload.
  • Chronic adaptation: ↑PVR → concentric RVH → ↓compliance → ↑RVEDP → systemic venous hypertension.
  • RV–PA uncoupling: RV Emax cannot match rising Ea → RV dilates → ↑wall stress → ↑O₂ demand → subendocardial ischaemia.
  • Coronary perfusion – the critical vulnerability: once RV systolic pressure ≥ aortic diastolic pressure, RV is perfused only in diastole (like the LV) → dependent on DBP.
  • Ventricular interdependence (death spiral): ↑PVR → RV dilates → D-shaped septum → ↓LV filling → ↓CO → ↓DBP → ↓RV perfusion → RV ischaemia → further ↓CO.
Key Anaesthetic Goals – ""Prevent the RV Failure Death Spiral""Avoid: ↑PVR (hypoxia, hypercapnia, acidosis, hypothermia, pain) · Avoid ↓systemic BP (maintain RV coronary perfusion) · Avoid ↓HR · Maintain RV preload without overload · Optimise RV contractility.

C. Anaesthetic Goals & Management4 marks

GoalIntervention
↓PVRFiO₂ ≥0.6, normoventilation (PaCO₂ 35–40), warming, analgesia, PEEP ≤5, avoid N₂O, continue PH therapy
Pulmonary vasodilatorsInhaled NO 10–40 ppm; inhaled iloprost/epoprostenol; IV sildenafil; milrinone (inodilator)
Maintain systemic BPVasopressin or phenylephrine preferred (↑SVR w/o ↑PVR); avoid vasodilators/high spinal
RV contractilityDobutamine, milrinone, adrenaline, levosimendan; avoid myocardial depressants (propofol bolus, ≥1 MAC volatile)
InductionSlow titrated GA (etomidate + ketamine + opioid); avoid high spinal/epidural; arterial line + CVC pre-induction; TOE intraoperatively
Examiner's PearlPH definition: mPAP ≥20 mmHg. PAH (Group 1): pre-capillary, PVR >2 WU, PAWP ≤15. RV death spiral: ↑PVR → RV dilates → D-septum → ↓LV filling → ↓CO → ↓DBP → RV ischaemia → death. Avoid hypoxia/hypercapnia/N₂O/↑PEEP/vasodilation. Vasopressor of choice: vasopressin. Pulmonary vasodilator: inhaled NO.
References: Simonneau G et al. Eur Respir J 2019;53:1801913. Price LC et al. Eur Respir Rev 2010;19:35-42. ESC/ERS PH Guidelines 2022. Miller's Anaesthesia, 9th Ed.
"
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 132 person Asked by .
bookmark_add

Cardiac Implantable Electronic Devices — Pacemakers, ICDs & EMI Write short notes on: (a) Classification of pacemakers (NBG code) and indications for perioperative pacing [3] (b) Electromagnetic interference (EMI) from diathermy – mechanisms and prevention [4] (c) Perioperative management of implantable cardioverter-defibrillators (ICDs) [3].

description Clinical Response
" Q77 - Cardiac Implantable Electronic Devices — Pacemakers, ICDs & EMI
Q77 · Paper II · 10 MARKS · Short Notes

Cardiac Implantable Electronic Devices — Pacemakers, ICDs & EMI

Question: Write short notes on: (a) Classification of pacemakers (NBG code) and indications for perioperative pacing [3] (b) Electromagnetic interference (EMI) from diathermy – mechanisms and prevention [4] (c) Perioperative management of implantable cardioverter-defibrillators (ICDs) [3].
Core ConceptOver 750,000 pacemakers and 250,000 ICDs are implanted annually. These devices can be profoundly affected by surgical diathermy. A structured approach involving the implanting cardiologist, device interrogation, and reprogramming is mandatory for safe surgery.

A. NBG Code & Perioperative Pacing3 marks

NBG 5-letter code: I=Chamber paced, II=Chamber sensed, III=Response to sensing, IV=Rate modulation, V=Multisite.

ModeMeaningUse
VVIPaces/senses ventricle, inhibited by native beatChronic AF with bradycardia
DDDPaces & senses both chambers (most physiological)SND + AV block; commonest modern PM
DOO/VOOFixed-rate, no sensing (asynchronous)Used intraoperatively when EMI risk high; R-on-T risk
DDIPaces/senses both, inhibited onlyPrevents rate-adaptive tracking in AF

Temporary pacing indications: complete heart block, symptomatic bradycardia refractory to atropine, new bifascicular block + prolonged PR, post-cardiac surgery bradyarrhythmia.

B. EMI from Diathermy4 marks

  • Mechanism: diathermy generates high-frequency current (0.3–3 MHz) → CIED leads act as antennae → device misreads EMI as intrinsic activity → inhibition (asystole if PM-dependent) or ICD misreads as VF → inappropriate shock.
  • Risk factors: monopolar diathermy (highest risk), proximity <15 cm, pacemaker dependence.
  • Prevention: use bipolar diathermy where possible; short bursts <1 s at lowest power; reprogram to DOO/VOO if monopolar within 15 cm or PM-dependent; alternatives – ultrasonic scalpel/LigaSure; external pacing/defib pads available; re-interrogate post-op.

C. Perioperative ICD Management3 marks

  • ICDs risk inappropriate shocks (up to 40 J) if EMI misread as VF → pain, myocardial damage, R-on-T VF.
  • Pre-op: cardiology consult + device interrogation; suspend shock therapies before monopolar diathermy (reprogramming preferred; magnet effect is manufacturer-dependent – do not assume universal).
  • Continue pacing function if PM-dependent; attach external defibrillator pads (AP position) throughout.
  • Post-op: re-enable ICD therapies before leaving monitored area.
  • Emergency (repeated shocks): stop diathermy, apply magnet, confirm rhythm, external defibrillation if true VF.
Examiner's PearlNBG: Chamber Paced–Sensed–Response–Rate–Multisite. DOO/VOO = asynchronous, EMI-safe but R-on-T risk. Monopolar diathermy → PM inhibition (asystole) or ICD inappropriate shock. Reprogram to DOO/VOO + suspend ICD therapies if monopolar within 15 cm. Magnet suspends ICD therapy – manufacturer dependent. Always have external pacing/defib ready.
References: Crossley GH et al. Heart Rhythm 2011;8:1114-1154. BHRS/BSIR/BCS Advisory Statement 2015. Miller's Anaesthesia, 9th Ed, Ch 35.
"
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 133 person Asked by .
bookmark_add

Surgical Positioning — Physiological Effects, Nerve Injuries &amp; Complications Write short notes on: (a) Physiological effects of the supine, prone, and lateral decubitus positions on cardiovascular and respiratory function [4] (b) Nerve injuries associated with surgical positioning &ndash; mechanisms, at-risk nerves and prevention [4] (c) Specific complications of the prone and lithotomy positions [2].

description Clinical Response
" Q78 - Surgical Positioning — Physiological Effects, Nerve Injuries & Complications
Q78 · Paper II · 10 MARKS · Short Notes

Surgical Positioning — Physiological Effects, Nerve Injuries & Complications

Question: Write short notes on: (a) Physiological effects of the supine, prone, and lateral decubitus positions on cardiovascular and respiratory function [4] (b) Nerve injuries associated with surgical positioning – mechanisms, at-risk nerves and prevention [4] (c) Specific complications of the prone and lithotomy positions [2].
Core ConceptPositioning is a shared responsibility between anaesthetist, surgeon and scrub team. Position-related injuries are the second most common cause of claims against anaesthetists (after awareness). Nerve injuries may not manifest until the patient regains consciousness.

A. Physiological Effects of Positions4 marks

PositionCVS EffectsRespiratory Effects
Supine↑venous return vs upright; aortocaval compression in pregnancy >20 wk → supine hypotension syndromeFRC ↓25%
Prone↓venous return if abdomen unsupported; use prone frame to free abdomen; cardiac arrest – CPR near-impossibleFRC ↑; V/Q matching improves (ARDS proning); airway oedema in prolonged cases
Lateral decubitusDependent lung ↑perfusion; non-dependent ↑ventilation → V/Q mismatch (worse with OLV)Compounded by thoracotomy mediastinal shift
Trendelenburg↑venous return/CO; ↑ICP transiently; ↑intragastric pressureFRC ↓; steep version → ocular hypertension/AION risk

B. Position-Related Nerve Injuries4 marks

NerveAt-risk PositionPresentation/Prevention
Ulnar (commonest, 28%)Elbow flexed on table edgeRing/little finger paraesthesia; pad elbow, avoid flexion >90°
Brachial plexusArm abducted >90° + head turned; sternal retractionWhole-arm weakness; axillary roll CAUDAL to axilla, limit abduction ≤90°
Common peronealLithotomy stirrups at fibular headFoot drop; pad fibular head
RadialArm hanging over table edgeWrist drop (""Saturday night palsy""); support arm
FemoralLithotomy with excessive hip flexion; retractors↓knee extension; limit hip flexion <90°

C. Prone & Lithotomy Complications2 marks

  • Prone: PION/CRAO (visual loss – risk >4h, hypotension, blood loss); facial/airway oedema – cuff-leak test before extubation; pressure areas (breasts, genitalia, knees).
  • Lithotomy: lower-limb compartment syndrome (>4h elevation); peroneal nerve injury; rapid leg-lowering → sudden ↑preload → pulmonary oedema risk in poor LV function.
Examiner's PearlUlnar nerve = commonest claim (28%) – pad elbow, avoid flexion >90°. Brachial plexus: axillary roll CAUDAL to axilla. Prone: PION/CRAO – padded eyes, cuff-leak before extubation. Lithotomy >4h → compartment syndrome risk → fasciotomy.
References: Welch MB et al. Anesthesiology 2009;111:490-497. Warner MA et al. Anesthesiology 1994;81:1332-1340. Miller's Anaesthesia, 9th Ed, Ch 41.
"
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 134 person Asked by .
bookmark_add

Vascular Surgery — Open AAA vs EVAR, Cross-Clamping &amp; Spinal Cord Protection Compare open AAA repair with EVAR &ndash; patient selection, physiological insults and anaesthetic implications [4]. Describe the haemodynamic consequences of aortic cross-clamping and unclamping [3]. Outline strategies for spinal cord protection during thoracoabdominal aortic surgery [3].

description Clinical Response
" Q79 - Vascular Surgery — Open AAA vs EVAR, Cross-Clamping & Spinal Cord Protection
Q79 · Paper II · 10 MARKS · Long Answer

Vascular Surgery — Open AAA vs EVAR, Cross-Clamping & Spinal Cord Protection

Question: Compare open AAA repair with EVAR – patient selection, physiological insults and anaesthetic implications [4]. Describe the haemodynamic consequences of aortic cross-clamping and unclamping [3]. Outline strategies for spinal cord protection during thoracoabdominal aortic surgery [3].
Core ConceptAortic aneurysm repair is the highest-risk elective surgery in anaesthesia – open repair carries 3–5% 30-day mortality (40–50% for rupture). EVAR offers lower 30-day mortality but requires lifelong surveillance.

A. Open AAA vs EVAR4 marks

FeatureOpen RepairEVAR
TechniqueGA + thoracic epidural, laparotomy, aortic cross-clampGA/regional/local; fluoroscopy; usually no cross-clamp
InsultMajor – clamp instability, blood loss, 3–6h durationMinimal – contrast nephropathy, endoleak risk, radiation
30-day mortality3–5% elective; 40–50% rupture1–2% elective; no long-term survival benefit (EVAR trial 1)
LimitationsHigh-risk cardiorespiratory diseaseRequires suitable anatomy (60–70% eligible)

B. Cross-Clamping & Unclamping3 marks

  • Clamping (""afterload crisis""): sudden ↑↑SVR/MAP above clamp; ↑LV afterload → risk of pulmonary oedema; ↓flow below clamp (kidney, cord, gut ischaemia). Manage: vasodilators (GTN/SNP) + TOE guidance; mannitol before clamping.
  • Unclamping: dramatic ↓↓SVR/MAP from ischaemic vasodilated bed + metabolite washout (lactate, K⁺, CO₂) → ""declamping hypotension"". Manage: slow release over 3–5 min, volume load pre-unclamp, vasopressors ready, treat hyperkalaemia/acidosis.

C. Spinal Cord Protection (TAAA)3 marks

  • Artery of Adamkiewicz (T9–T12) is dominant anterior spinal artery feeder – ligated segmental arteries risk anterior cord syndrome; incidence 2–17% (Crawford II highest, 15–40%).
  • CSF drainage: lumbar drain, target SCPP ≥70 mmHg (SCPP = MAP − CSF pressure).
  • Mild hypothermia: systemic or epidural cord cooling ↓metabolic rate.
  • MAP ≥80–90 mmHg throughout and 48h post-op.
  • Segmental artery reimplantation where feasible.
  • Neuromonitoring: MEPs (most sensitive for anterior cord) – requires TIVA, no paralysis.
Examiner's PearlEVAR: ↓30-day mortality but no long-term survival benefit (EVAR trial 1); lifelong surveillance needed. Cross-clamp = afterload crisis (vasodilators + TOE); unclamp = declamping hypotension (slow release + volume + vasopressors). Spinal cord: CSF drain (SCPP ≥70) + MAP ≥80–90 + hypothermia + MEP monitoring + TIVA. Artery of Adamkiewicz T9–T12.
References: EVAR trial participants. Lancet 2005;365:2179-2186. Acher CW. Semin Vasc Surg 2000;13:265-272. Miller's Anaesthesia, 9th Ed, Ch 72.
"
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 135 person Asked by .
bookmark_add

Anaesthesia for Neurosurgery — Craniotomy, Awake Craniotomy &amp; IONM Describe the anaesthetic management of craniotomy for supratentorial tumour resection [4]. Explain the conduct of awake craniotomy including asleep-awake-asleep technique [3]. Outline the principles of intraoperative neurophysiological monitoring (IONM) [3].

collections Question Diagrams & Reference Images (3)
Question Reference Diagram
zoom_in View Image
Question Reference Diagram
zoom_in View Image
Question Reference Diagram
zoom_in View Image
description Clinical Response
" Q80 - Anaesthesia for Neurosurgery — Craniotomy, Awake Craniotomy & IONM
Q80 · Paper II · 10 MARKS · Long Answer

Anaesthesia for Neurosurgery — Craniotomy, Awake Craniotomy & IONM

Question: Describe the anaesthetic management of craniotomy for supratentorial tumour resection [4]. Explain the conduct of awake craniotomy including asleep-awake-asleep technique [3]. Outline the principles of intraoperative neurophysiological monitoring (IONM) [3].
Core ConceptCraniotomy for brain tumour requires simultaneous management of raised ICP, haemodynamic stability, brain relaxation, and rapid emergence for neurological assessment. Awake craniotomy enables resection near eloquent cortex with real-time mapping.

A. Craniotomy — Anaesthetic Management4 marks

  • Pre-op: assess ICP signs, continue anticonvulsants, dexamethasone 8–16 mg/day, review imaging (eloquence, midline shift).
  • Monitoring: invasive arterial line, CVC, urinary catheter, BIS/entropy, NMB monitoring.
  • Induction: smooth – propofol + remifentanil TCI; avoid coughing/straining; scalp block/local before pin insertion.
  • Maintenance: TIVA preferred (preserves autoregulation, ↓ICP, ↓PONV, preserves MEPs); mannitol 0.5–1 g/kg for brain relaxation; mild hyperventilation (PaCO₂ 32–35, short term only); head-up 15–30°.
  • Emergence: smooth – avoid coughing/bucking (↑ICP/haemorrhage risk); lidocaine 1.5 mg/kg before extubation; immediate neuro assessment.

B. Awake Craniotomy — Asleep-Awake-Asleep3 marks

  • Indication: tumour in/near eloquent cortex (motor, speech, sensory areas) – enables real-time cortical mapping.
  • Phase 1 (Asleep): TIVA + LMA/nasal airway; scalp block (6 nerves) + pin-site infiltration.
  • Phase 2 (Awake): wean TIVA; nasal airway + O₂ ± dexmedetomidine (sedation without respiratory depression); cortical mapping + resection with patient testing.
  • Phase 3 (Asleep): restart TIVA for closure.
  • Complications: airway loss (seizure), intraoperative seizure (cold saline terminates), patient distress, PONV.

C. Intraoperative Neurophysiological Monitoring3 marks

ModalityMonitorsAnaesthetic Implication
MEPsAnterior/motor corticospinal tractsTIVA mandatory – volatile >0.5 MAC suppresses; NMB must be 0
SSEPsPosterior/sensory cordMore volatile-tolerant (≤0.5 MAC possible)
EEGCortical activity/ischaemiaUsed in carotid endarterectomy for shunt decision
EMGCranial nerve/nerve rootNMB abolishes signal – avoid or monitor TOF carefully
Examiner's PearlBrain relaxation: mannitol 0.5–1 g/kg + short hyperventilation (PaCO₂ 32–35) + head-up + TIVA. Awake craniotomy: scalp block (6 nerves) + dexmedetomidine. IONM: TIVA mandatory for MEPs (volatile >0.5 MAC suppresses); NMBs abolish EMG/MEPs. MEP alert: ≥50% amplitude ↓ or ≥10% latency ↑.
References: Berger MS et al. Neurosurgery 2005;56:232-240. Szelenyi A et al. Br J Anaesth 2016;116:i25-38. Miller's Anaesthesia, 9th Ed, Ch 57.
"
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 136 person Asked by .
bookmark_add

Obstetric Emergencies — Category 1 CS, Failed Intubation &amp; Cord Prolapse Outline the decision-to-delivery interval (DDI) targets for caesarean section categories and the anaesthetic strategy for Cat 1 CS [3]. Describe the management of failed intubation in the pregnant patient [4]. Discuss the management of cord prolapse as an obstetric emergency [3].

description Clinical Response
" Q81 - Obstetric Emergencies — Category 1 CS, Failed Intubation & Cord Prolapse
Q81 · Paper II · 10 MARKS · Long Answer

Obstetric Emergencies — Category 1 CS, Failed Intubation & Cord Prolapse

Question: Outline the decision-to-delivery interval (DDI) targets for caesarean section categories and the anaesthetic strategy for Cat 1 CS [3]. Describe the management of failed intubation in the pregnant patient [4]. Discuss the management of cord prolapse as an obstetric emergency [3].
Core ConceptObstetric anaesthesia manages two patients simultaneously. Maternal airway risk is 8× higher than non-pregnant (1:390 vs 1:2,230). Failed obstetric intubation remains a recurring cause of maternal death (NAP4, MBRRACE).

A. CS Categories & Cat 1 Anaesthesia3 marks

CategoryTarget DDIPreferred Anaesthesia
1 – Immediate threat30 min (<15 min if acute compromise)GA (fastest) or rapid spinal (<5 min) or epidural top-up
2 – Compromise, not life-threatening75 minSpinal preferred
3 – No compromise, early deliveryAgreed timeSpinal preferred
4 – ElectiveScheduledSpinal (overwhelmingly preferred)

Cat 1 GA (RSI): pre-oxygenation, left lateral tilt 15°, thiopentone/propofol + suxamethonium, cricoid pressure until tube confirmed, FiO₂ 0.5 + volatile 1 MAC, oxytocin infusion (no bolus). Awake extubation only.

B. Failed Intubation (DAS Obstetric 2015)4 marks

  • Call for help immediately; after one failed optimised attempt → declare ""failed intubation"".
  • Maintain oxygenation: facemask/CPAP, 2-person BMV, 2nd-generation LMA (ProSeal/Supreme) if BMV fails.
  • Critical decision: wake the patient up (if foetal condition allows) OR proceed with LMA anaesthesia (if immediate risk unacceptable – cord prolapse, severe bradycardia).
  • If LMA used: maintain cricoid pressure, limit tidal volume, surgeon ready for rapid delivery.
  • CICO: scalpel-bougie cricothyrotomy immediately – leading cause of anaesthesia-related maternal death (NAP4).
  • Extubation is also high-risk – extubate only when fully awake.

C. Cord Prolapse Management3 marks

  • Umbilical cord descends alongside/ahead of presenting part after membrane rupture → compression → foetal bradycardia/asphyxia.
  • Immediate: manual elevation of presenting part (maintained until delivery); bladder filling 500–750 mL saline; knee-chest/Trendelenburg position; do NOT apply traction to exposed cord.
  • Definitive: emergency Cat 1 CS – DDI <30 min (<15 min if severe bradycardia); epidural top-up fastest if in situ; rapid spinal if <5 min setup; GA if spinal too slow or foetal condition critical.
Examiner's PearlCat 1 DDI: 30 min (<15 min if cord prolapse/acute bradycardia). Failed intubation: DECLARE → maintain oxygenation (2nd-gen LMA) → wake vs proceed decision → CICO = scalpel-bougie immediately. Cord prolapse: manual elevation + bladder filling + Trendelenburg → Cat 1 CS; epidural top-up = fastest.
References: Mushambi MC et al. Anaesthesia 2015;70:1286-1306. MBRRACE-UK 2023. NICE NG192 (2021).
"
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 137 person Asked by .
bookmark_add

Paediatric Pain and Regional Anaesthesia — Caudal Block, Pain Scales &amp; Opioid-Free Strategy Describe the anatomy and technique of the caudal block including drugs and dosing [4]. Outline validated pain assessment tools for preverbal children [3]. Describe multimodal opioid-free analgesia strategies for paediatric day surgery [3].

collections Question Diagrams & Reference Images (1)
Question Reference Diagram
zoom_in View Image
description Clinical Response
" Q82 - Paediatric Pain and Regional Anaesthesia — Caudal Block, Pain Scales & Opioid-Free Strategy
Q82 · Paper II · 10 MARKS · Long Answer

Paediatric Pain and Regional Anaesthesia — Caudal Block, Pain Scales & Opioid-Free Strategy

Question: Describe the anatomy and technique of the caudal block including drugs and dosing [4]. Outline validated pain assessment tools for preverbal children [3]. Describe multimodal opioid-free analgesia strategies for paediatric day surgery [3].
Core ConceptNeonates and infants have fully developed nociceptive pathways from 28 weeks gestation and may be MORE sensitive to pain than adults. The caudal block is the commonest paediatric regional technique, providing excellent infraumbilical analgesia.

A. Caudal Block — Anatomy, Technique, Dosing4 marks

  • Anatomy: sacral hiatus (failure of S4–S5 laminae fusion), bounded by sacral cornua, covered by sacrococcygeal membrane. Dural sac extends to S3–S4 in infants (vs S2 adults) – ↑ dural puncture risk.
  • Technique: under GA, 21G needle at 45° through membrane (""give"" felt), angle to 20–30°, advance 2–3 mm; aspirate; test dose with adrenaline 1:200,000; inject slowly; USG guidance where available.
Volume (mL/kg)LevelSurgery
0.5Sacral (S1–S5)Perineal, scrotal, anal, distal hypospadias
1.0Lower thoracic (T10)Inguinal hernia, orchidopexy, circumcision
1.25Mid-thoracic (T4–T6)Upper abdominal (rarely used)

Additives: clonidine 1–2 mcg/kg (3–4× duration); dexmedetomidine 1 mcg/kg; S(+) ketamine 0.5 mg/kg; morphine 30 mcg/kg (needs monitored overnight setting).

B. Pain Assessment Tools (Preverbal)3 marks

ToolAgeNotes
FLACC2 mo–7 yr5 domains, 0–10; ≥4 = treat
NIPSPreterm–6 mo6 indicators, most validated neonatal scale
Wong-Baker FACES3–18 yr (self-report)6 faces, may be confounded by emotion
CRIES32–60 wk postconceptualStandard post-op neonatal assessment

C. Opioid-Free Analgesia (Day Surgery)3 marks

  • Rationale: opioids → PONV, respiratory depression (esp. ex-premature, OSA), parental opioid phobia.
  • Multimodal (ERAS Paediatric): regional block (caudal + clonidine) + paracetamol 15–20 mg/kg + NSAID (avoid ketorolac in tonsillectomy) + dexmedetomidine (↓emergence delirium) + sub-anaesthetic ketamine 0.25–0.5 mg/kg.
Examiner's PearlArmitage dosing: 0.5 mL/kg sacral, 1.0 mL/kg T10, 1.25 mL/kg T4–T6. Clonidine 1–2 mcg/kg additive prolongs 3–4×. Infant dural sac to S3–S4 – ↑puncture risk. FLACC 2mo–7yr, ≥4=treat. Opioid-free day surgery = caudal + paracetamol + NSAID + dexmedetomidine + ketamine.
References: Armitage EN. Anaesthesia 1979;34:396-398. Lönnqvist PA, Morton NS. Br J Anaesth 2005;95:59-68. Merkel SI et al. Pediatr Nurs 1997;23:293-297. APAGBI 2012.
"
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 138 person Asked by .
bookmark_add

Point-of-Care Ultrasound (POCUS) in Anaesthesia — Lung, FATE &amp; Gastric Describe the technique and findings of lung ultrasound in the perioperative period [3]. Explain the basic cardiac POCUS assessment &ndash; FATE protocol &ndash; and its perioperative utility [4]. Outline gastric ultrasound for aspiration risk assessment [3].

description Clinical Response
" Q83 - Point-of-Care Ultrasound (POCUS) in Anaesthesia — Lung, FATE & Gastric
Q83 · Paper II · 10 MARKS · Short Notes

Point-of-Care Ultrasound (POCUS) in Anaesthesia — Lung, FATE & Gastric

Question: Describe the technique and findings of lung ultrasound in the perioperative period [3]. Explain the basic cardiac POCUS assessment – FATE protocol – and its perioperative utility [4]. Outline gastric ultrasound for aspiration risk assessment [3].
Core ConceptPOCUS changes clinical management in 20–30% of cases and is now expected competency in anaesthesia – the stethoscope of the 21st century.

A. Lung Ultrasound3 marks

  • A-lines: normal aeration or pneumothorax (with absent lung sliding).
  • Lung sliding: rules OUT pneumothorax; M-mode ""seashore"" (present) vs ""barcode"" (absent = pneumothorax).
  • B-lines: ≥3/interspace = interstitial syndrome (pulmonary oedema, ARDS, pneumonia).
  • Consolidation: liver-like tissue + dynamic air bronchograms = pneumonia.
  • Pleural effusion: anechoic collection + ""spine sign"".
  • BLUE protocol: diagnoses cause of acute dyspnoea at bedside within 3 minutes.

B. Cardiac POCUS — FATE Protocol4 marks

ViewAssessesKey Question
Subcostal 4-chamberEffusion/tamponade, RV:LV ratio, IVCTamponade? Volume responsive?
Parasternal long axisLV, LVOT, valvesLV function good/poor? Valve pathology?
Parasternal short axisLV cross-section, D-signRV overload/PE? Regional wall abnormality?
Apical 4-chamberRV:LV ratio, TRRV dilated? LV function?

Utility: unexplained hypotension diagnosis in minutes; detects tamponade pre-induction; guides fluid resuscitation (IVC); classifies PEA arrest.

C. Gastric Ultrasound3 marks

  • Technique: right lateral decubitus, curvilinear probe, antrum between liver and aorta.
  • Grade 0: empty in both positions – low risk.
  • Grade 1: fluid in right lateral only – low risk if no other factors.
  • Grade 2: content in both positions – HIGH risk → RSI indicated.
  • CSA formula: gastric volume = 27 + 14.6×right-lateral CSA − 1.28×age.
Examiner's PearlLung: A-lines normal/PTX; B-lines (≥3) = interstitial fluid; absent sliding = pneumothorax. FATE: SC4C (tamponade/IVC), PLAX (LV function), PSAX (D-sign=RV overload), A4C (RV:LV). Gastric: Grade 0/1 low risk, Grade 2 high risk → RSI. IVC <2cm + >50% collapse = fluid responsive.
References: Lichtenstein DA. Chest 2008;134:117-125. Jensen MB et al. Eur J Emerg Med 2004;11:15-23. Van de Putte P, Perlas A. Br J Anaesth 2014;113:12-22.
"
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 139 person Asked by .
bookmark_add

Pharmacology of Local Anaesthetics — Structure, Mechanism, Differential Block &amp; Toxicity Describe the structure-activity relationship and mechanism of action of local anaesthetics [3]. Explain differential nerve block and its basis [3]. Describe the pharmacokinetic determinants of systemic toxicity and compare bupivacaine, ropivacaine and lidocaine [4].

description Clinical Response
" Q84 - Pharmacology of Local Anaesthetics — Structure, Mechanism, Differential Block & Toxicity
Q84 · Paper II · 10 MARKS · Long Answer

Pharmacology of Local Anaesthetics — Structure, Mechanism, Differential Block & Toxicity

Question: Describe the structure-activity relationship and mechanism of action of local anaesthetics [3]. Explain differential nerve block and its basis [3]. Describe the pharmacokinetic determinants of systemic toxicity and compare bupivacaine, ropivacaine and lidocaine [4].
Core ConceptLocal anaesthetics are the cornerstone of regional anaesthesia. Their mechanism (voltage-gated Na⁺ channel block) is simple, but pharmacokinetics are complex. Systemic toxicity (LAST) is potentially fatal yet preventable.

A. Structure-Activity Relationship & Mechanism3 marks

  • Structure: aromatic ring (lipophilic) – intermediate chain (ester or amide) – tertiary amine (hydrophilic, determines pKa).
  • Esters (procaine, chloroprocaine): plasma cholinesterase hydrolysis, PABA metabolite → allergy. Amides (lidocaine, bupivacaine, ropivacaine): hepatic CYP450 metabolism, true allergy rare.
  • Mechanism: unionised form penetrates membrane → ionised cation binds Na⁺ channel intracellularly (use-dependent block) → prevents depolarisation. Lower pKa → faster onset.

B. Differential Nerve Block3 marks

  • Block sequence: autonomic (B-fibres) → pain/temperature (C, Aδ) → motor (Aα).
  • Determinants: fibre diameter, myelination (saltatory conduction needs fewer nodes blocked), firing frequency (use-dependent block favours high-frequency C-fibres).
  • Clinical application: dilute LA (0.1% bupivacaine) → sensory block with motor sparing (""walking epidural""); higher concentration (0.5%) → complete motor block.

C. LAST Pharmacokinetics & Drug Comparison4 marks

Risk factors: injection site vascularity (intercostal>caudal>epidural>brachial plexus>SC), total dose, adrenaline reduces peak level 30–50%.

Toxicity sequence: CNS more sensitive than CVS – excitatory (perioral tingling, tinnitus, agitation) → inhibitory (seizures, coma); bupivacaine can cause CVS collapse WITHOUT CNS warning.

FeatureLidocaineBupivacaineRopivacaine
CardiotoxicityLow, easily reversedHIGH – refractory VF (""fast in, slow out"")Lower than bupivacaine (S-enantiomer)
Max dose (plain/+adr)3/7 mg/kg2/2.5 mg/kg3/4 mg/kg
Duration1–2h4–8h3–6h
Preferred useIVRA, top-upSpinal (hyperbaric)Epidural, large-volume PNB
Examiner's PearlAmides: hepatic CYP450. Esters: plasma cholinesterase (PABA allergy). Mechanism: ionised cation blocks Na⁺ channel intracellularly. Differential block: Aδ/C before Aα – use dilute LA. Bupivacaine ""fast in, slow out"" → refractory VF; ropivacaine safer (S-enantiomer).
References: Covino BG, Vassallo HG. Local Anaesthetics 1976. AAGBI LAST Guidelines 2010 (updated 2023). Miller's Anaesthesia, 9th Ed, Ch 36.
"
lock Protected Clinical Document • Pulse App • Screenshots Strictly Prohibited
QUESTION 140 person Asked by .
bookmark_add

Anaesthesia for Renal Transplantation — ESRD, Fluid Strategy &amp; Immunosuppressants Describe the perioperative physiological challenges in a patient with end-stage renal disease presenting for renal transplantation [4]. Outline the fluid and haemodynamic management strategy to optimise early graft function [3]. Discuss the anaesthetic implications of immunosuppressant drugs [3].

collections Question Diagrams & Reference Images (1)
Question Reference Diagram
zoom_in View Image
description Clinical Response
" Q85 - Anaesthesia for Renal Transplantation — ESRD, Fluid Strategy & Immunosuppressants
Q85 · Paper II · 10 MARKS · Long Answer

Anaesthesia for Renal Transplantation — ESRD, Fluid Strategy & Immunosuppressants

Question: Describe the perioperative physiological challenges in a patient with end-stage renal disease presenting for renal transplantation [4]. Outline the fluid and haemodynamic management strategy to optimise early graft function [3]. Discuss the anaesthetic implications of immunosuppressant drugs [3].
Core ConceptRenal transplantation is the definitive treatment for ESRD. Anaesthesia must address ESRD physiology, optimise graft perfusion at reperfusion, and manage immunosuppressant effects. Primary non-function and delayed graft function are largely preventable.

A. ESRD Physiological Challenges4 marks

SystemChangesImplication
CardiovascularHypertension, LVH, CAD (40–50%), pericardial effusion, arrhythmiasPre-op cardiac assessment vital; K⁺ <5.5 before surgery; protect AV fistula
HaematologicalNormochromic anaemia, platelet dysfunctionHb target 100–120 g/L; DDAVP if bleeding risk
Electrolytes/Acid-baseHyperkalaemia, metabolic acidosis, hypocalcaemiaAvoid suxamethonium if K⁺ >5.0; avoid normal saline
Drug handling↓Renal clearance, ↑free drug fractionAvoid morphine, vecuronium; use atracurium/cisatracurium, fentanyl
GIGastroparesis → ↑aspiration riskRSI precautions, PPI premedication

B. Fluid & Haemodynamic Strategy3 marks

  • Goal: optimise graft perfusion at reperfusion – ↓delayed graft function; target CVP 10–15 mmHg (higher than usual).
  • Fluid: Hartmann's/PlasmaLyte preferred over normal saline (avoids hyperchloraemic acidosis/hyperkalaemia).
  • MAP ≥70–80 mmHg at reperfusion (new graft has no autoregulation); noradrenaline or cautious dopamine if needed.
  • Mannitol 0.25–0.5 g/kg before reperfusion – osmotic diuresis + ROS scavenging; methylprednisolone 250–500 mg IV before reperfusion.

C. Immunosuppressant Implications3 marks

DrugImplication
Ciclosporin/TacrolimusNephrotoxic, hepatotoxic, hypertension, ↑infection risk; continue perioperatively
CorticosteroidsHPA suppression – steroid cover (hydrocortisone 100 mg 6-hrly); hyperglycaemia
Azathioprine/MycophenolateBone marrow suppression; azathioprine + allopurinol = FATAL interaction
Basiliximab (anti-IL-2R)Induction only; rare anaphylaxis
Examiner's PearlESRD drugs: atracurium/cisatracurium (Hofmann), fentanyl (no active metabolite); avoid morphine, vecuronium, suxamethonium if K⁺>5.0, normal saline. Fluid: Hartmann's, CVP 10–15, MAP ≥70–80 at reperfusion. Mannitol pre-reperfusion. Azathioprine+allopurinol = fatal marrow suppression. Steroid cover mandatory.
References: Sprung J et al. Anesthesiology 2006;105:405-424. Pöge U et al. Br J Anaesth Educ 2013;13:70-74. Miller's Anaesthesia, 9th Ed.
"

Showing 131140 of 337 questions

account_tree

Subcategory Tree

Explore Anesthesia subcategories

folder_special Anesthesia
Main
lock

Category Subscription

Subscribe to Anesthesia to unlock this module and all nested subcategories.

  • check_circle Access Anesthesia & all subcategories
  • check_circle Detailed, Peer-Reviewed Answers
  • check_circle High-yield visual aids & imaging
Get Category Subscription arrow_forward
Secure 256-bit SSL Connection

Anatomical Models

Explore high-fidelity 3D visualizations included in premium modules.

Case Reviews

Real-world clinical scenarios narrated by senior consultants.

Pulse App